VANCOUVER, BC (OR REMOTE IN CANADA) / FULL TIME

Variational AI is radically accelerating the development of promising drug candidates by integrating chemistry and pharmacology expertise with the state‑of‑the‑art in machine learning. Traditional approaches to small molecule drug discovery require over ten years and two billion dollars, and their reliance on trial‑and‑error calls out for better predictive and generative models. The current industry standard has progressed little beyond shallow ML techniques and simple graph neural networks, largely due to the difficulty of integrating world‑class machine learning research with traditional chemistry and pharmacology approaches. Variational AI is building a generative foundation model for molecular structure and properties from the ground up. Over the past five years, we have been advancing the state‑of‑the‑art, and delivering projects to customers including Merck, Rakovina Therapeutics, and ImmVue Therapeutics.

We ar...